SNOA

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Peers: DERM CLDX PBYI XOMA VRNA KURA CUTR ADMA EVOK CBIO

Index	-	P/E	-	EPS (ttm)	-2.19	Insider Own	1.30%	Shs Outstand	1.70M	Perf Week	-6.60%
Market Cap	6.26M	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	1.68M	Perf Month	-15.98%
Enterprise Value	3.76M	PEG	-	EPS next Q	-	Inst Own	5.02%	Short Float	2.73%	Perf Quarter	23.49%
Income	-3.48M	P/S	0.37	EPS this Y	-	Inst Trans	4.10%	Short Ratio	0.04	Perf Half Y	16.83%
Sales	16.94M	P/B	1.60	EPS next Y	-	ROA	-25.26%	Short Interest	0.05M	Perf YTD	36.80%
Book/sh	2.30	P/C	2.06	EPS next 5Y	-	ROE	-76.14%	52W High	6.92 -46.82%	Perf Year	29.58%
Cash/sh	1.79	P/FCF	-	EPS past 3/5Y	58.27% 42.62%	ROIC	-83.27%	52W Low	1.75 110.29%	Perf 3Y	-93.16%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	4.20% -4.44%	Gross Margin	37.68%	Volatility	7.33% 6.13%	Perf 5Y	-97.54%
Dividend TTM	-	EV/Sales	0.22	EPS Y/Y TTM	55.11%	Oper. Margin	-18.42%	ATR (14)	0.24	Perf 10Y	-99.66%
Dividend Ex-Date	-	Quick Ratio	2.00	Sales Y/Y TTM	25.02%	Profit Margin	-20.54%	RSI (14)	41.05	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	2.85	EPS Q/Q	45.01%	SMA20	-5.00%	Beta	1.64	Target Price	12.00
Payout	-	Debt/Eq	0.14	Sales Q/Q	56.58%	SMA50	-10.42%	Rel Volume	0.01	Prev Close	3.65
Employees	168	LT Debt/Eq	0.10	Earnings	Nov 04 BMO	SMA200	9.08%	Avg Volume	1.24M	Price	3.68
IPO	Jan 25, 2007	Option/Short	No / Yes	EPS/Sales Surpr.	- -	Trades		Volume	18,081	Change	0.82%

Nov-06-25 04:01PM	Sonoma Pharmaceuticals to Exhibit at MEDICA 2025 in Dusseldorf (ACCESSWIRE)
Nov-04-25 08:56AM	Sonoma Pharmaceuticals Reports Second Fiscal Quarter 2026 Financial Results (ACCESSWIRE)
Oct-14-25 08:30AM	Sonoma Pharmaceuticals and Medline Industries Launch New HOCl Wound Cleanser for U.S. Hospitals (ACCESSWIRE)
Oct-07-25 08:30AM	Sonoma Pharmaceuticals Expands Market Reach with FDA Cosmetic Product Facility Registration and Microcyn-Based Cosmetic Product Listing Under MoCRA (ACCESSWIRE)
Sep-25-25 04:01PM	Sonoma Pharmaceuticals to Participate in the Lytham Partners Fall 2025 Investor Conference on September 30, 2025 (ACCESSWIRE)
08:30AM	Loading…
Aug-26-25 08:30AM	National Psoriasis Foundation Awards Seal of Recognition to Sonoma Pharmaceuticals for Reliefacyn Advanced (ACCESSWIRE)
Aug-19-25 08:50AM	Despite Fast-paced Momentum, Sonoma Pharmaceuticals (SNOA) Is Still a Bargain Stock (Zacks)
Aug-14-25 01:55PM	Sonoma Pharmaceuticals Soars 95% After Walmart, Amazon Retail Debut (GuruFocus.com) +72.67%
10:30AM	BC-Most Active Stocks (Associated Press Finance)
Aug-13-25 04:01PM	Sonoma Pharmaceuticals Announces Launch of Diaper Rash Product in Walmart and other U.S. Chains (ACCESSWIRE)
Aug-07-25 04:15PM	Sonoma Pharmaceuticals Reports First Fiscal Quarter 2026 Financial Results (ACCESSWIRE)
Jul-14-25 08:50AM	Sonoma Pharmaceuticals (SNOA) Is Attractively Priced Despite Fast-paced Momentum (Zacks)
Jul-10-25 04:00AM	The early winner in the 'Dexit' war for corporate relocations: Nevada (Yahoo Finance) +23.13%
Jun-17-25 04:10PM	Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2025 Financial Results (ACCESSWIRE)
May-20-25 10:35AM	Tesla's Texas Plan B if Delaware wont reinstate Elon Musk's pay. It's not about the money, says Elon. (Yahoo Finance)
09:34AM	Loading…
09:34AM	The Texas Plan B if Delaware wont reinstate Elon Musk's Tesla pay haul (Yahoo Finance)
Apr-22-25 04:01PM	Sonoma Pharmaceuticals Announces Registration of Acne Products in the United Kingdom and Launch of the Products in Leading U.K. Pharmacy Chain (ACCESSWIRE) +69.53%
Mar-27-25 08:50AM	Fast-paced Momentum Stock Sonoma Pharmaceuticals (SNOA) Is Still Trading at a Bargain (Zacks) -8.28%
Mar-26-25 12:44PM	Delaware passes law designed to stop more Elon Musks from leaving state (Yahoo Finance)
Mar-11-25 08:50AM	Why Fast-paced Mover Sonoma Pharmaceuticals (SNOA) Is a Great Choice for Value Investors (Zacks) +21.86%
Mar-10-25 04:01PM	Sonoma Pharmaceuticals Secures Extensive U.K. Regulatory Clearances of Key Wound Care and Dermatology Products by the Medicines & Healthcare Products Regulatory Agency (MHRA) (ACCESSWIRE) +40.20%
Feb-25-25 04:01PM	Sonoma Pharmaceuticals to Exhibit at 2025 American Academy of Dermatology Annual Meeting in Orlando (ACCESS Newswire)
Feb-05-25 04:05PM	Sonoma Pharmaceuticals Reports Third Fiscal Quarter 2025 Financial Results (ACCESSWIRE)
Dec-05-24 08:30AM	Sonoma Pharmaceuticals Successfully Transitions First Products to New EU MDR Requirements for Class IIb Medical Devices (ACCESSWIRE)
Nov-27-24 08:50AM	Despite Fast-paced Momentum, Sonoma Pharmaceuticals (SNOA) Is Still a Bargain Stock (Zacks)
Nov-21-24 04:06PM	Sonoma Pharmaceuticals Announces Relaunch of Prescription Dermatology and Eye Care Product Lines in the United States (ACCESSWIRE)
Nov-11-24 04:20PM	Sonoma Pharmaceuticals Receives New FDA 510(k) Clearance for Microcyn(R)-based Wound Care Hydrogel (ACCESSWIRE) +10.71% -13.23%
Nov-07-24 08:45AM	Sonoma Pharmaceuticals Reports Second Fiscal Quarter 2025 Financial Results (ACCESSWIRE)
Oct-31-24 04:01PM	Sonoma Pharmaceuticals to Exhibit at MEDICA 2024 in Dusseldorf (ACCESSWIRE) -7.59%
04:01PM	Sonoma Pharmaceuticals to Exhibit at MEDICA 2024 in Düsseldorf (ACCESS Newswire)
08:35AM	Loading…
Oct-22-24 08:35AM	Sonoma Pharmaceuticals Announces Expanded Partnership with Global Healthcare Distributor for Distribution of Wound Care Products in Canada (ACCESSWIRE)
Oct-21-24 04:01PM	Sonoma Pharmaceuticals to Present at Danisavage Financial Strategies, and LD Micro Main Event XVII Investor Conferences (ACCESSWIRE) -6.01%
Sep-19-24 08:30AM	Sonoma Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Rule (ACCESSWIRE) -10.93%
Sep-17-24 08:30AM	Sonoma Pharmaceuticals Receives New FDA 510(k) Clearance with Expanded Indications for Over-the-Counter Microcyn(R)-Based Solution (ACCESSWIRE) +23.52%
Sep-11-24 08:30AM	Sonoma Pharmaceuticals and EMC Pharma Announce Collaboration to Co-market an Expanded Eye Care Product Line (ACCESSWIRE)
Aug-28-24 06:10AM	Sonoma Pharmaceuticals Announces 1-for-20 Reverse Split of Outstanding Common Stock (ACCESSWIRE) -24.99%
Aug-26-24 08:30AM	Sonoma Pharmaceuticals and MicroSafe Group Announce that Nanocyn(R) Disinfectant & Sanitizer has been Approved by the Australian TGA as Effective Against Candida auris and C-Diff (ACCESSWIRE)
Aug-21-24 08:45AM	Sonoma Pharmaceuticals Announces Partnership with Global Healthcare Distributor for Distribution of Wound Care Products in the United States (ACCESSWIRE) -8.45%
Aug-12-24 07:30AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday (InvestorPlace) -9.48%
Aug-08-24 04:10PM	Sonoma Pharmaceuticals Reports First Fiscal Quarter 2025 Financial Results (ACCESSWIRE) +13.49% -19.70%
Jul-15-24 08:50AM	Sonoma Pharmaceuticals (SNOA) Is Attractively Priced Despite Fast-paced Momentum (Zacks)
Jul-12-24 07:41AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday (InvestorPlace)
Jul-09-24 07:30AM	Sonoma Pharmaceuticals Celebrates 20 Years of Selling Wound Care Products in Europe and Announces New Distributor in Ukraine (ACCESSWIRE) -7.27%
Jun-28-24 08:50AM	Sonoma Pharmaceuticals (SNOA) Shows Fast-paced Momentum But Is Still a Bargain Stock (Zacks)
Jun-18-24 07:37AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday (InvestorPlace) +13.95%
Jun-17-24 09:52PM	SNOA Stock Earnings: Sonoma Pharmaceuticals Misses Revenue for Q4 2024 (InvestorPlace) -5.76%
05:00PM	Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2024 Financial Results (ACCESSWIRE)
May-30-24 07:47AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday (InvestorPlace) -21.15%
May-09-24 07:30AM	Sonoma Pharmaceuticals Announces MicrocynAH for Animal Health Now Available Through Menards Home Improvement Stores (ACCESSWIRE)
Apr-09-24 07:30AM	Sonoma Pharmaceuticals Announces Expansion of Negative-Pressure Wound Therapy Products for Use in the United States (ACCESSWIRE) +6.33%
Apr-04-24 07:30AM	Sonoma Pharmaceuticals Reports Recent Publication from Australia Highlighting Potential for Microdox in Managing Urinary Tract Infections (ACCESSWIRE)
Mar-28-24 04:01PM	Sonoma Pharmaceuticals to Present at Trickle Research and LD Micro Investor Conferences (ACCESSWIRE) -7.88%
Mar-27-24 07:30AM	Sonoma Pharmaceuticals Highlights Safety Advantages of its Microcyn Products in Light of Growing Concerns of Benzene in Many Other Topicals (ACCESSWIRE)
Feb-08-24 04:10PM	Sonoma Pharmaceuticals Reports Third Fiscal Quarter 2024 Financial Results (ACCESSWIRE)
Jan-23-24 07:30AM	Sonoma Pharmaceuticals Introduces Lumacyn Clarifying Mist, an All Natural, Over-the-Counter Skincare Product for Daily Use (ACCESSWIRE)
Jan-09-24 09:15AM	NovaBay Pharmaceuticals and Sonoma Pharmaceuticals Agree to Market Avenova-branded Products in the European Union Through Sonomas Extensive Distributor Network (Business Wire)
Nov-13-23 04:10PM	Sonoma Pharmaceuticals Reports Second Fiscal Quarter 2024 Financial Results (ACCESSWIRE) +11.38%
Nov-03-23 07:30AM	Sonoma Pharmaceuticals Announces U.S. Launch of Next Generation Advanced Solution for Pulse Lavage Irrigation at the Symposium on Advanced Wound Care Fall Conference (ACCESSWIRE) +8.40%
Oct-26-23 09:10AM	Sonoma Pharmaceuticals, Inc. Announces Pricing of $1.7 Million Public Offering of Common Stock (ACCESSWIRE) -49.83%
Sep-21-23 09:35AM	Dawson James Securities Announces October Date for 8th Annual Small Cap Growth Conference (GlobeNewswire)
Aug-15-23 07:30AM	National Eczema Association Awards Seal of Acceptance to Sonoma Pharmaceuticals for Reliefacyn Advanced (ACCESSWIRE)
Aug-10-23 04:15PM	Sonoma Pharmaceuticals Reports First Fiscal Quarter 2024 Financial Results (ACCESSWIRE)
Aug-03-23 07:30AM	Sonoma Pharmaceuticals Announces Appointment of Hye Jin Chung, M.D. to Scientific Advisory Board (ACCESSWIRE)
Jun-22-23 07:30AM	Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2023 Financial Results (ACCESSWIRE)
Jun-09-23 04:40PM	Sonoma Pharmaceuticals Shares Soar 44% After Introducing New Product (Investopedia) +44.33% -11.43%
Jun-08-23 04:01PM	Sonoma Pharmaceuticals Introduces Next Generation Solution for Pulse Lavage Irrigation in the European Union (ACCESSWIRE) +5.40%
Apr-19-23 01:30PM	Benign Growth For Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA) Underpins Its Share Price (Simply Wall St.)
Apr-11-23 07:30AM	Sonoma Pharmaceuticals Introduces Podiacyn, an All Natural, Over-the-Counter Podiatry Product for Daily Foot Care (ACCESSWIRE)
Mar-28-23 04:15PM	Sonoma Pharmaceuticals to Exhibit at Upcoming CPHI North America Conference in Philadelphia (ACCESSWIRE) +15.03% -18.03%
Mar-02-23 07:30AM	Sonoma Pharmaceuticals and MicroSafe Group Announce New EPA Claims and Green Seal Certification for Nanocyn(R) Hospital-Grade Disinfectant (ACCESSWIRE)
Feb-14-23 04:30PM	Sonoma Pharmaceuticals Reports Third Quarter 2023 Financial Results (ACCESSWIRE)
Jan-31-23 07:30AM	Sonoma Pharmaceuticals Announces Partnership with Daewoong Pharmaceutical for Distribution of Primocyn Skin Care in South Korea (ACCESSWIRE)
Jan-25-23 07:30AM	Sonoma Pharmaceuticals and EMC Pharma Announce Department of Defense DAPA Registration for Microcyn(R) Rx Products (ACCESSWIRE) +40.83%
Jan-04-23 07:30AM	Sonoma Pharmaceuticals Launches Two New Products Expanding Its Line of Office Dispense Products Exclusively for Dermatologists and Medical Spas (ACCESSWIRE) -6.30%
Nov-17-22 05:33AM	Sonoma Pharmaceuticals Second Quarter 2023 Earnings: US$0.33 loss per share (vs US$0.043 loss in 2Q 2022) (Simply Wall St.)
Nov-14-22 04:15PM	Sonoma Pharmaceuticals Reports Second Quarter 2023 Financial Results (ACCESSWIRE) +7.21%
Oct-27-22 04:01PM	Sonoma Pharmaceuticals Launches Two New Dermatological Products for Over-The-Counter Use in the United States (ACCESSWIRE)
Oct-06-22 04:15PM	Sonoma Pharmaceuticals to Exhibit at Upcoming CPHI Conference in Frankfurt, Germany (ACCESSWIRE) -8.81%
Aug-11-22 04:30PM	Sonoma Pharmaceuticals Reports First Quarter 2023 Financial Results (ACCESSWIRE)
Aug-02-22 04:30PM	Sonoma Pharmaceuticals Launches MicrocynVS(R) Line of Products Exclusively for Veterinarian Use and Announces Partnership with DV Medical Supply (ACCESSWIRE) +7.96%
Jul-13-22 04:45PM	Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2022 Financial Results (ACCESSWIRE)
Jun-01-22 06:00AM	Sonoma Pharmaceuticals and MicroSafe Group DMCC Announce that U.S. EPA has Added Nanocyn® Hospital-Grade Disinfectant to List N for Use Against COVID-19 (Business Wire) -11.59%
May-03-22 06:00AM	Sonoma Pharmaceuticals and MicroSafe Group DMCC Announce EPA Approval for Nanocyn® Hospital-Grade Disinfectant in the U.S. (Business Wire) +31.55%
Mar-30-22 11:20AM	Sonoma Pharma Launches New Urinary Tract Infection Product In New Zealand, Australia, South Africa (Benzinga) +13.39%
06:00AM	Sonoma Pharmaceuticals Launches New Urinary Tract Infection Product Through Distributors in New Zealand, Australia and South Africa (Business Wire)
Feb-11-22 04:30PM	Sonoma Pharmaceuticals Reports Third Quarter FY 2022 Financial Results (Business Wire) -6.90%
Jan-28-22 09:38AM	HBC Financial Services, PLLC Buys Apollo Investment Corp, Lockheed Martin Corp, Airbnb Inc, ... (GuruFocus.com)
Jan-20-22 04:40PM	Sonoma Pharmaceuticals Announces Expansion of its Partner Network for Oral and Dental Products in the U.S. and China (Business Wire) -10.35%
Jan-05-22 04:55PM	Sonoma Pharmaceuticals to Present at H.C. Wainwright BioConnect Virtual Conference January 10-13, 2022 (Business Wire)
Nov-15-21 08:00AM	Sonoma Pharmaceuticals Reports Second Quarter FY 2022 Financial Results (Business Wire)
Nov-09-21 07:00AM	Sonoma Pharmaceuticals and Dyamed Biotech Announce Expanded Long-Term Partnership for New Territories and Products in Southeast Asia (Business Wire)
Oct-15-21 07:44AM	The Daily Biotech Pulse: Moderna's Booster Shot Gets FDA Panel Backing, Decision Day For Avadel, Silence Therapeutics Strikes Licensing Deal, MiNK IPO (Benzinga) +5.56%
07:00AM	Sonoma Pharmaceuticals and MicroSafe Group Announce that Nanocyn® Disinfectant & Sanitizer Has Been Approved by the Australia TGA with a 15 Second SARS-CoV-2 (COVID-19) Kill Time (Business Wire)
Sep-30-21 12:50PM	Sonoma Pharmaceuticals (NASDAQ:SNOA) Has Debt But No Earnings; Should You Worry? (Simply Wall St.) -9.27%
Sep-29-21 03:37AM	48 Biggest Movers From Yesterday (Benzinga) -12.02%
Sep-28-21 02:37PM	Mid-Afternoon Market Update: Dow Tumbles 500 Points; Sonoma Pharmaceuticals Shares Spike Higher (Benzinga) +30.65%
12:05PM	Mid-Day Market Update: Nasdaq Down 2.5%; IHS Markit Posts Upbeat Earnings (Benzinga)
07:00AM	Sonoma Pharmaceuticals Launches Its First Over-the-Counter Products in the U.S. on Amazon and a New Consumer-Focused Product on Amazon in Europe (Business Wire)
Aug-20-21 12:19PM	Why Sonoma Pharmaceuticals Shares Are Trading Lower Today (Benzinga) -23.93%
Aug-19-21 01:19PM	Why Sonoma Pharmaceuticals Shares Are Surging Higher Today (Benzinga) +50.65%

Sonoma Pharmaceuticals, Inc. is a global healthcare leader in the development and production of stabilized hypochlorous acid (HOCl) products. Its products are used for a wide range of applications, including wound care, eye care, nasal care, oral care, dermatological conditions, podiatry, animal health care, and non-toxic disinfectants. The company was founded by Hojabr Alimi and Linda Alimi in April 1999 and is headquartered in Boulder, CO.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	SEC Form 4
Gottfurcht Grant	10% Owner	Jan 03 '25	Proposed Sale	2.70	86,111	232,500	Jan 03 02:27 PM
Gottfurcht Grant	Open Market	Jan 02 '25	Proposed Sale	2.69	30,000	80,684	Jan 02 03:39 PM
Gottfurcht Grant	Open Market Purchase	Dec 31 '24	Proposed Sale	2.73	17,806	48,562	Jan 02 11:13 AM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

Sonoma Pharmaceuticals Inc

Upgrade your FINVIZ experience